ANTX
AN2 Therapeutics Inc
5.10$
-9.6%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +5.3% | +0.0% | -5.0% | +10.5% | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +148.6% | +30.4% | +8.7% | -3.1% | +18.9% | +25.8% | +3.8% | +36.9% | +13.0% | +6.6% | +3.4% | -1.8% | -17.1% | -31.8% | -34.9% | +42.5% | -58.4% | +118.8% | -1.7% | -2.0% | -10.7% | – | |
| – | +123.9% | +76.7% | +12.3% | +15.0% | +77.3% | -8.1% | +11.4% | +8.9% | -24.4% | +22.5% | +3.9% | -6.5% | +2.5% | -6.6% | -7.9% | +19.8% | +4.4% | -24.3% | -19.8% | +56.3% | -24.2% | – | |
| – | +143.8% | +38.7% | +9.5% | +1.2% | +34.5% | +13.9% | +6.0% | +28.6% | +3.5% | +9.5% | +3.5% | -2.8% | -13.2% | -11.8% | -38.6% | +34.2% | -37.5% | +39.1% | -7.2% | +13.3% | -15.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +650.0% | +66.7% | – | – | +744.4% | +89.0% | +119.3% | -24.2% | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -175.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -15,722.4% | – | – | – | – | -2,307.3% | – | -1,219.1% | – | – | -207.3% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.